We are pleased to announce that at the end of November 2024, the Proktosedon brand joined the USP Zdrowie portfolio. This brand has been present on the Polish market for over 20 years and currently holds the number 3 position in the hemorrhoid treatment category.

The acquisition of the Proktosedon brand, one of the largest in the hemorrhoid treatment category, perfectly complements the USP Zdrowie portfolio, increasing the scale of operations in the OTC market in Poland and reflecting the company’s growth strategy in the country.